(International Research Group on High Dilution and Very Low Dose Effects)

The aim of the GIRI is to bring together pharmacologists, biologists, physicians, chemists, physicists and mathematicians to communicate, exchange experiences and develop joint research projects; the distinctive feature of the research activities of the group is the study of ultra low dose impulses or very high dilutions, homoeopathics included. Although the mechanism of action of the very dilute solutions of active principles on biological systems is an important concern of the GIRI, the Group major interest is directed towards the possible medicinal and therapeutic relevance of very low doses and high dilutions.

1. The GIRI is an independent international scientific society.

II. The Board is composed of 15 members. One third of the members is renewed every three years by a vote of the members of the GIRI.

III. The Executive Committee is composed of a President, 2 Vice- presidents, a Secretary, a Treasurer and an Editor. This Committee is renewed every three years. The President can only be reelected once.

IV. The Scientific Committee is composed of three members, chosen by the Executive Committee. The Scientific Committee is renewed every two years. Its function is to review the Abstracts submitted for presentation at the meetings.

V. Admission of new members: The candidates for admission to the GIRI must send the following to the secretary of the GIRI: a detailed CV indicating clearly the candidates' University Diplomas, his present situation, his reasons for wanting to become a member of the GIRI, a list of his publications and a letter of recommendation from a sponsor who must be a GIRI member. The new members will be elected at the General Assembly of the GIRI during the next meeting.

VI. GIRI Meetings: The GIRI organizes one meeting every year.

VII. Membership fees: 200 FF per year to be paid in French Francs only*.

VIII. General Assembly: there will be a General Assembly during each annual GIRI meeting.